勝利證券(08540.HK)中期收益約2956萬港元 同比增加約7.2%
格隆匯8月8日丨勝利證券(08540.HK)公吿,截至2024年6月30日止6個月的收益約為2956萬港元,同比增加約7.2%,反映來自配售及包銷服務、虛擬資產服務、資產管理服務及財務諮詢服務的收益增加,補償了與2023年相比,2024年上半年來自證券╱期貨經紀服務、融資服務、手續費服務及保險諮詢服務收益減少。
截至2024年6月30日止6個月的虧損約為582萬港元,同比增加約47.5%,主要是由於為加強資訊科技基礎設施而增加的員工成本,以及投資物業公允價值虧損增加所致。截至2024年6月30日止6個月已宣派中期股息每股0.10港仙(截至2023年6月30日止6個月:每股0.80港仙)。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.